Benzoxaborinine, New Chemotype for Carbonic Anhydrase Inhibition:
Journal
Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531
Informations de publication
Date de publication:
08 Oct 2024
08 Oct 2024
Historique:
medline:
8
10
2024
pubmed:
8
10
2024
entrez:
8
10
2024
Statut:
aheadofprint
Résumé
The benzoxaborinine scaffold, a homologue of benzoxaborole with an additional carbon atom in the boracycle, shows significant potential in developing new therapeutic agents. This study reports the synthesis, inhibition assays against four human carbonic anhydrase (hCA, EC 4.2.1.1) isoforms, and anti-melanoma evaluation of 7-aryl(thio)ureido-substituted benzoxaborinines. Some derivatives, particularly compound
Identifiants
pubmed: 39378331
doi: 10.1021/acs.jmedchem.4c01516
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM